Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Baldwin

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 14, 2018
Factors correlated with repeated aspirin dosing during aspirin desensitizationCharles F Schuler, James L Baldwin, Alan P Baptist
Allergy and Asthma Proceedings|July 26, 2013
Recurrent perioperative anaphylaxis in a 54-year-old manTimothy J Franxman, Matthew J Greenhawt, James L Baldwin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 10, 2017
Frequency and severity of reactions to a 325-mg aspirin dose during desensitizationCharles F Schuler, James L Baldwin, Alan P Baptist
Teaching and Learning in Medicine|October 4, 2005
Elective rotations and their impact on resident and faculty decision makingAlan P Baptist, Tricia S Tang, Linping Duan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 18, 2014
Systemic reactions to inhalant immunotherapy using 1:1 target dosingChristine L Holland, Kiela M Samuels, James L Baldwin, et al.
The Journal of Biological Chemistry|December 7, 2005
Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activityYong-Zheng Wu, Yefim Manevich, James L Baldwin, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
Bioorganic Chemistry|April 17, 2002
A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesteraseSu H Hung, K S Madhusoodanan, James A Beres, et al.
Plos One|March 16, 2021
Accurate point-of-care serology tests for COVID-19Charles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
Frontiers in Immunology|February 27, 2023
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testingKelly M O'Shea, Charles F Schuler, Jesse Chen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 14, 2018
Factors correlated with repeated aspirin dosing during aspirin desensitizationCharles F Schuler, James L Baldwin, Alan P Baptist
Allergy and Asthma Proceedings|July 26, 2013
Recurrent perioperative anaphylaxis in a 54-year-old manTimothy J Franxman, Matthew J Greenhawt, James L Baldwin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 10, 2017
Frequency and severity of reactions to a 325-mg aspirin dose during desensitizationCharles F Schuler, James L Baldwin, Alan P Baptist
Teaching and Learning in Medicine|October 4, 2005
Elective rotations and their impact on resident and faculty decision makingAlan P Baptist, Tricia S Tang, Linping Duan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 18, 2014
Systemic reactions to inhalant immunotherapy using 1:1 target dosingChristine L Holland, Kiela M Samuels, James L Baldwin, et al.
The Journal of Biological Chemistry|December 7, 2005
Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activityYong-Zheng Wu, Yefim Manevich, James L Baldwin, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
Bioorganic Chemistry|April 17, 2002
A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesteraseSu H Hung, K S Madhusoodanan, James A Beres, et al.
Plos One|March 16, 2021
Accurate point-of-care serology tests for COVID-19Charles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
Frontiers in Immunology|February 27, 2023
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testingKelly M O'Shea, Charles F Schuler, Jesse Chen, et al.
Pageof 3